CDMO Samsung Biologics Increases Capacity With October Opening of Fourth Manufacturing Plant
The CDMO built three plants in its first seven years of operation, with 364,000 liters of capacity at its Songdo, South Korea, headquarters. Samsung Biologics is now nearing the completion of its fourth plant in Songdo.